Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eline Houben"'
Autor:
Carlos E. Durán, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibánez, Mònica Sabaté, Xavier Vidal, Elena Ballarín, Gabriel Sanfélix-Gimeno, Clara Rodríguez-Bernal, Salvador Peiró, Aníbal García-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brøgger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women.Objective: To measure the impact of the 2018 revis
Externí odkaz:
https://doaj.org/article/97c75f28f2b14a79838ac1ce448b894e
Autor:
Michiel L Bots, Frank L J Visseren, Aarent RT Brand, Eline Houben, Irene D Bezemer, Ron MC Herings, Gert J de Borst
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Objectives Pharmacological treatment of peripheral arterial disease (PAD) comprises of antiplatelet therapy (APT), blood pressure control and cholesterol optimisation. Guidelines provide class-I recommendations on the prescription, but there are litt
Externí odkaz:
https://doaj.org/article/caf7a57203034f5081b8656cf9e4b1cb
Autor:
Eline Houben, Stefanie L. Groenland, Joost W. van der Heijden, Alexandre E. Voskuyl, Hiëronymus J. Doodeman, Erik L. Penne
Publikováno v:
BMC Nephrology, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background In ANCA-associated vasculitis the acute phase of the disease is often preceded by prodromal symptoms. The aim of the present study was to analyze the relation between the duration of the prodromal phase and renal damage. Methods P
Externí odkaz:
https://doaj.org/article/7f7c4c26d0504be98fe8fbb83ac20ca6
Publikováno v:
Clinical Epidemiology, 15, 1-11. Dove Medical Press Ltd.
Overbeek, J A, Swart, K M A, Houben, E, Penning-van Beest, F J A & Herings, R M C 2023, ' Completeness and Representativeness of the PHARMO General Practitioner (GP) Data : A Comparison with National Statistics ', Clinical Epidemiology, vol. 15, pp. 1-11 . https://doi.org/10.2147/CLEP.S389598
Overbeek, J A, Swart, K M A, Houben, E, Penning-van Beest, F J A & Herings, R M C 2023, ' Completeness and Representativeness of the PHARMO General Practitioner (GP) Data : A Comparison with National Statistics ', Clinical Epidemiology, vol. 15, pp. 1-11 . https://doi.org/10.2147/CLEP.S389598
Jetty A Overbeek, Karin MA Swart, Eline Houben, Fernie JA Penning-van Beest, Ron MC Herings Department Research, PHARMO Institute for Drug Outcomes Research, Utrecht, the NetherlandsCorrespondence: Jetty A Overbeek, Department Research, PHARMO Instit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e1a7ae6790de699b47e28dff8e2b82
https://research.vumc.nl/en/publications/96c5148a-81ba-4d3c-b142-9baa24f8602b
https://research.vumc.nl/en/publications/96c5148a-81ba-4d3c-b142-9baa24f8602b
Autor:
Alejandro Arana, Anton Pottegård, Josephina G Kuiper, Helen Booth, Johan Reutfors, Brian Calingaert, Lars Christian Lund, Elizabeth Crellin, Marcus Schmitt-Egenolf, James A Kaye, Karin Gembert, Kenneth J Rothman, Helle Kieler, Daniel Dedman, Eline Houben, Lia Gutiérrez, Jesper Hallas, Susana Perez-Gutthann
Publikováno v:
Clinical Epidemiology
Alejandro Arana,1 Anton Pottegård,2 Josephina G Kuiper,3 Helen Booth,4 Johan Reutfors,5 Brian Calingaert,6 Lars Christian Lund,2 Elizabeth Crellin,4 Marcus Schmitt-Egenolf,5,7 James A Kaye,8 Karin Gembert,5 Kenneth J Rothman,8 Helle Kieler,5 Danie
Autor:
Simon Carette, Erik L. Penne, Eline Houben, Alexandre E. Voskuyl, Christian Pagnoux, Arielle Mendel
Publikováno v:
Revue du Rhumatisme (Edition Francaise), 88(4), 279-283. Elsevier Masson
Houben, E, Mendel, A, Carette, S, Voskuyl, A E, Penne, E L & Pagnoux, C 2021, ' Facteurs prédictifs d’événements cardiovasculaires mortels et non mortels dans la vascularite à ANCA : données de la cohorte Toronto CanVasc ', Revue du Rhumatisme (Edition Francaise), vol. 88, no. 4, pp. 279-283 . https://doi.org/10.1016/j.rhum.2021.03.013
Houben, E, Mendel, A, Carette, S, Voskuyl, A E, Penne, E L & Pagnoux, C 2021, ' Facteurs prédictifs d’événements cardiovasculaires mortels et non mortels dans la vascularite à ANCA : données de la cohorte Toronto CanVasc ', Revue du Rhumatisme (Edition Francaise), vol. 88, no. 4, pp. 279-283 . https://doi.org/10.1016/j.rhum.2021.03.013
Resume Objectifs Les personnes atteintes de vascularite a ANCA presentent un risque accru d’evenements cardiovasculaires. L’objectif de cette etude etait d’evaluer les facteurs predictifs d’evenements cardiovasculaires chez des patients attei
Autor:
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary J Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G Tektonidou
Publikováno v:
Annals of the Rheumatic Diseases, 81(6):221733, 768-779. BMJ Publishing Group
Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733
Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S R, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, 221733, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733
Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733
Drosos, G C, Vedder, D, Houben, E, Boekel, L, Atzeni, F, Badreh, S, Boumpas, D T, Brodin, N, Bruce, I N, González-Gay, M Á, Jacobsen, S R, Kerekes, G, Marchiori, F, Mukhtyar, C, Ramos-Casals, M, Sattar, N, Schreiber, K, Sciascia, S, Svenungsson, E, Szekanecz, Z, Tausche, A-K, Tyndall, A, van Halm, V, Voskuyl, A, Macfarlane, G J, Ward, M M, Nurmohamed, M T & Tektonidou, M G 2022, ' EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome ', Annals of the Rheumatic Diseases, vol. 81, no. 6, 221733, pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733
ObjectiveTo develop recommendations for cardiovascular risk (CVR) management in gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren’s syndrome (SS), systemic lupus erythematosus (SLE) and antiphosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bacd35324df9922aaf466a97c014ddb
https://research.vumc.nl/en/publications/cd7270c7-01fd-4eae-8b0d-5bae1915ab26
https://research.vumc.nl/en/publications/cd7270c7-01fd-4eae-8b0d-5bae1915ab26
Autor:
Elisabeth Smits, Felicita Andreotti, Eline Houben, Harry J. G. M. Crijns, Sylvia Haas, George Spentzouris, Tania Schink, Rosa Gini, Claudia Bartolini, Fernie Penning-van Beest, Ron Herings
Publikováno v:
Drugs-Real World Outcomes, 9(2), 199-209. Springer International Publishing AG
Smits, E, Andreotti, F, Houben, E, Crijns, H J G M, Haas, S, Spentzouris, G, Schink, T, Gini, R, Bartolini, C, Penning-van Beest, F & Herings, R 2022, ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation : Real-World Analyses from the Netherlands, Italy and Germany ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w
Drugs-real world outcomes, 9(2):199–209
Drugs-Real World Outcomes, 9(2), 199-209. Adis International Ltd
Smits, E, Andreotti, F, Houben, E, Crijns, H J G M, Haas, S, Spentzouris, G, Schink, T, Gini, R, Bartolini, C, Penning-van Beest, F & Herings, R 2022, ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation : Real-World Analyses from the Netherlands, Italy and Germany ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w
Drugs-real world outcomes, 9(2):199–209
Drugs-Real World Outcomes, 9(2), 199-209. Adis International Ltd
Background Direct oral anticoagulants are available for patients with atrial fibrillation. Objective This study compared adherence and persistence of once-daily (QD) vs twice-daily (BID) direct oral anticoagulants in patients with atrial fibrillation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3a6bd049eb0949b2fbc74da950505f
https://research.vumc.nl/en/publications/95904649-183e-43f9-b624-d7201237d612
https://research.vumc.nl/en/publications/95904649-183e-43f9-b624-d7201237d612
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS ANCA-associated vasculitis (AAV) has been associated with increased risk of cardiovascular (CV) events. The purpose of the present study was to asses cardiovascular risk determinants and outcomes in a two-centre prospective cohort
Publikováno v:
Houben, E, Benson, R J, Steegers, E A P & Herings, R M C 2022, ' Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands ', Epilepsy and Behavior, vol. 127, 108549 . https://doi.org/10.1016/j.yebeh.2021.108549
Epilepsy and Behavior, 127:108549. Academic Press
Epilepsy and Behavior, 127:108549. Academic Press Inc.
Epilepsy and Behavior, 127:108549. Academic Press
Epilepsy and Behavior, 127:108549. Academic Press Inc.
Background: Anti-seizure medications (ASMs) are used to treat conditions such as epilepsy and bipolar disorder. Some of these drugs are associated with an increased risk of congenital malformations and adverse developmental outcomes. Objectives: To e